AMSTERDAM - As regulators craft revisions to the European regulations governing pediatric and orphan drug development, the time is now for stakeholders to gather their thoughts and prepare their ...
Ten years ago, the European Commission created a new regulation as part of an effort to try to encourage more pediatric research. But in the years since, companies have been slow to increase their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results